Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG SECOND QUARTER 2024 FINANCIAL RESULTS AND ADVANCES PITOLISANT HIGH-DOSE PROGRAM TOWARD EXPECTED PDUFA DATE IN 2028
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG FIRST QUARTER FINANCIAL RESULTS AND ACCELERATION OF ITS GROWTH STRATEGY; ADVANCES PITOLISANT FRANCHISE TO EXTEND REVENUE POTENTIAL BEYOND 2040; STRENGHTENS SLEEP/WAKE LEADERSHIP AND DIVERSIFIES
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | DEFA14A: Others
Harmony Biosciences | DEF 14A: Definitive information statements
Harmony Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS AND BUSINESS UPDATES
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K/A: Current report (Amendment)
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2023 FINANCIAL RESULTS
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
Harmony Biosciences | 8-K: Current report
No Data
No Data